For the Inventor, By the Inventor

Enter assignee name

Exonhit Therapeutics, Sa

USPTO Granted Patents = 25

EPO Patents = 3

Forward Citations = 82

Loading Chart...

Loading Chart...

34 inventors (with patents filed for the assignee):

Bertrand Leblond (13 out of 23 patents)

John E Donello (12 out of 136 patents)

Thierry Taverne (11 out of 16 patents)

4. Fabien J Schweighoffer (10 out of 21 patents)

5. Eric Beausoleil (9 out of 16 patents)

6. Laurent Bracco (6 out of 9 patents)

7. Laurent Desire (5 out of 6 patents)

8. Matthew P Pando (5 out of 5 patents)

9. Bruno Tocque (5 out of 15 patents)

10. Rong Yang (4 out of 28 patents)

11. Anne-Sophie Casagrande (4 out of 5 patents)

12. Cedric Chauvignac (3 out of 3 patents)

13. Eric Beusoleil (2 out of 3 patents)

14. Lauren M Luhrs (2 out of 8 patents)

15. Annelies Resink (2 out of 2 patents)

25 patents: Sort by Forward Citations

1. 9902710 - Substituted 6, 7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (PDE 10A) (2018-02-27),

2. 9828349 - 1-aryl-1-hydroxy-2,3-diamino-propyl amines, 1-heteroaryl-1-hydroxy-2,3-diamino-propyl amines and related compounds having analgesic and/or immuno stimulant activity (2017-11-28),

3. 9670181 - Substituted 6,7-dialkoxy-3-isoquinolinol derivatives as inhibitors of phosphodiesterase 10 (PDE 10A) (2017-06-06),

4. 9278943 - Methods of using as analgesics 1-benzyl-1-hydroxy-2, 3-diamino-propyl amines, 3-benzyl-3-hydroxy-2-amino-propionic acid amides and related compounds (2016-03-08),

5. 9200016 - Substituted 6, 7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (PDE 10A) (2015-12-01),

6. 8835463 - Compounds having analgesic and/or immunostimulant activity (2014-09-16),

7. 8772316 - Substituted 6,7-dialkoxy-3-isoquinolinol derivatives as inhibitors of phosphodiesterase 10 (PDE10A) (2014-07-08),

8. 8629165 - Methods for treating cognitive disorders (2014-01-14),

9. 8513288 - 1-aryl-1-hydroxy-2,3-diamino-propyl amines, 1-heteroaryl-1-hydroxy-2,3-diamino-propyl amines and related compounds having analgesic and/or immuno stimulant activity (2013-08-20),

10. 8481701 - Process and method for diagnosing Alzheimer's disease (2013-07-09),

11. 8431599 - 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic and/or immuno stimulant activity (2013-04-30),

12. 8288556 - 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic and/or immuno stimulant activity (2012-10-16),

13. 8173683 - Methods for treating cognitive disorders (2012-05-08),

14. 8003375 - Qualitative differential screening (2011-08-23),

15. 7923579 - Tricyclic hydroxamate and benzamide derivatives, compositions and methods (2011-04-12),

Exonhit Therapeutics, SA is a biotechnology company that specializes in the development of innovative therapeutics for various diseases. With a focus on diagnosing and treating cancer, the company aims to improve patient outcomes and overall quality of life. Exonhit Therapeutics utilizes cutting-edge technologies and research to discover novel therapies and biomarkers. Through collaborations with leading academic institutions and industry partners, they strive to advance the field of precision medicine. Visit their website for more information about their groundbreaking work in the biotechnology industry.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

25 Patents

#184 in Paris

#812 in France

#24,910 in the World

Exonhit Therapeutics, Sa

Forward Citations = 82

34 inventors:

Bertrand Leblond (13 out of 23 patents)

John E Donello (12 out of 136 patents)

Thierry Taverne (11 out of 16 patents)

4. Fabien J Schweighoffer (10 out of 21 patents)

5. Eric Beausoleil (9 out of 16 patents)

Please report any incorrect information to support@idiyas.com

Loading…